Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2006; 12(39): 6366-6370
Published online Oct 21, 2006. doi: 10.3748/wjg.v12.i39.6366
Published online Oct 21, 2006. doi: 10.3748/wjg.v12.i39.6366
MBZ group | QC group | |
n = 61 | n = 61 | |
Sex | ||
Male: n (%) | 28 (45.9) | 26 (42.6) |
Female: n (%) | 33 (54.1) | 35 (57.3) |
Age (yr) | ||
Mean (range) | 8.2 (5-15) | 9.7 (5-15) |
MBZ group | QC group | |
n = 61 | n = 61 | |
Cure rate | 48 (78.7%) | 51 (83.6%) |
Any adverse event | 14 (22.9%) | 36 (59%) |
Abdominal pain | 11 (18 %) | 10 (16.3%) |
Vomiting | 3 (4.9%) | 14 (22.9%) |
Nausea | 3 (4.9%) | 14 (22.9%) |
Headache | 1 (1.6%) | 11 (18%) |
Yellowish coloration of the skin | - | 15 (24.6%) |
- Citation: Cañete R, Escobedo AA, González ME, Almirall P. Randomized clinical study of five days apostrophe therapy with mebendazole compared to quinacrine in the treatment of symptomatic giardiasis in children. World J Gastroenterol 2006; 12(39): 6366-6370
- URL: https://www.wjgnet.com/1007-9327/full/v12/i39/6366.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i39.6366